| INTRODUCTION
The lifetime incidence of epilepsy is 1:26 people. 1 Approximately one third of people with epilepsy have seizures that are refractory to current antiseizure drugs, and the estimated risk for sudden unexpected death in epilepsy (SUDEP) in the refractory population is dramatically increased from 1:1000 to~1:150 people each year. 2, 3 The pathologic mechanisms mediating SUDEP events are not understood; however, risk factors include uncontrolled seizures, generalized tonicclonic (GTC) seizures, age, and cardiac arrhythmias. 2, [4] [5] [6] [7] The mechanisms underlying SUDEP are elusive primarily because it is rarely clinically witnessed. Of the witnessed cases, the majority report a partial or GTC seizure, [4] [5] [6] [7] which is associated with dysfunctional respiratory response reflexes, 8 lowered blood oxygen saturation followed by a period of increased breathing rate, cardiac arrhythmia/bradycardia, apnea, respiratory arrest, and asystole. [4] [5] [6] [7] Although it is clear that respiratory arrest contributes to the terminal SUDEP event, it is unknown whether a progressive respiratory dysfunction develops in susceptible individuals that may contribute to the pathology that culminates in death. The Kcna1 gene encodes for the Kv1.1 alpha subunit of the delayed rectifier potassium channel, which participates in the repolarization of the neuronal membrane potential, action potential properties, neurotransmitter release, synaptic integration, and network oscillatory behavior. 9, 10 Kcna1-null (Kcna1 À/À ) mice develop spontaneous recurrent seizures including myoclonic seizures, clonus, and generalized tonicclonic seizures around the third week of their life. 9, 11, 12 We have recently demonstrated that seizures progressively become more frequent and severe until the mice die at the early age of postnatal day (P) 42 AE 1.3, 12 although the background strain of the mouse influences the severity of seizures and mortality. 11 A genetic variant in Kcna1 has been identified in a clinical SUDEP case. 13 Kcna1 À/À mice phenocopy human SUDEP and experience a GTC seizure, cardiac arrhythmias, and asystole prior to death. 14 Although chemically provoked seizures elicited minimal cardiorespiratory effects in wild-type mice, similarly provoked seizures in Kcna1 À/À mice often result in periictal apneas, decreased blood oxygen saturation, and sudden spreading depolarization in the dorsal medulla followed by death. 15 These studies indicate that the respiratory responses of Kcna1 À/À mice ultimately fail following the final GTC. Here, we tested the hypothesis that Kcna1 À/À mice exhibit progressive respiratory dysfunction, which is associated with age-dependent susceptibility to sudden death (SD).
| MATERIAL AND METHODS

| Animals
Kcna1-null mice on a C3HeB/FeJ congenic background were bred and housed in the animal resource facilities at Creighton University School of Medicine in a temperature-(25°C) and humidity-(50-60%) controlled, pathogen-free environment on a 12-h light/dark cycle. Food and water were provided ad libitum. Male and female mice were used. No gender differences were detected in this study. have succumbed to SUDEP. 12 Mice were allowed to acclimate in the NAM chamber for 10-15 min, exposed to nebulized phosphate-buffered saline (PBS), and then challenged with increasing doses of methacholine (MCh; 6, 12, 24, 48, 100, and 200 mg/mL, 45 lL for 30 s). Each challenge was followed immediately by a 3-min recording period (Buxco FinePointe acquisition software V2.3.1.9). The independent measurement of both nasal and thoracic air flow allows the NAM to measure several more respiratory parameters than whole body plethysmography. Accordingly, peak expiratory flow (PEF), peak inspiratory flow (PIF), time of inspiration (T i ), time of expiration (T e ), frequency of breathing (f), minute ventilation (V E ), tidal volume (V T ), respiratory drive (V T /T i ), and specific airway resistance (sRaw) were determined. To account for varying body weights, f, PIF, PEF, V E , and V T were normalized to the weights of individual animals.
| Seizure monitoring
The NAM chamber physically restricted the ability to conduct electroencephalography (EEG) recordings; therefore only convulsive seizures were quantified. 14 were as follows: Kcna1 forward was 5'-GCATCGACAACACCACAGTC-3'; Kcna1 reverse was 5'-CGGCGGCTGAGGTCACTGT-CAGAGGCTAAGT-3'; Gapdh forward was 5'-TGAAGG TCGGTGTGAACGGATTT GGC-3'; and Gapdh reverse was 5'-ATGTAGGCCATGAGGTCCACCAC-3' (IDT's Primer Quest software2). Cycling conditions: 95°C/10 min, 40 cycles of 95°C/30 s, 72°C/30 s. Each RT-qPCR was performed using 3 biologic samples in technical triplicates, and melt curve analyses were completed to ensure the specificity of amplification. Calculations of the Kcna1 gene expression relative to Gapdh were based on the differences in threshold cycles using the 2 -DDCt method. 18 
| Immunofluorescent Western blot
| Reagents and statistical analysis
Unless otherwise specified, all reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA). All data are presented as mean AE standard error (SE). Statistical significance was determined with Prism6 software (Graphpad Software Inc., La Jolla, CA, USA) using either an unpaired t-test, 1-way analysis of variance (ANOVA) or 2-way ANOVA for genotype and age with an appropriate post hoc test. EC 50 values for MCh were calculated from concentration-response curves by nonlinear regression analysis.
3 | RESULTS
| Kcna1
À/À mice have increased respiratory drive and blood oxygen desaturation with increased probability of SD We determined respiratory endpoints during 3 age ranges-P32-36, P40-46, and P48-56-when up to~30%,~55%, and 90%, respectively, of Kcna1 À/À mice have succumbed to SD. 12 For simplicity, we refer to these groups as SD30, SD55, and SD90. Most baseline breathing parameters were similar. The most notable change occurred in the SD90 Kcna1 À/À mice cohort, which had the highest probability of imminent SD at the time of the respiratory experiments. 12 V T was significantly increased in SD90 Kcna1 À/À mice when compared to age-matched Kcna1 +/+ controls (P < .01;
; Figure 1A ). In addition, as the probability of SD rose, Kcna1 À/À respiratory drive (V T /T i ) and peak inspiratory flow were significantly increased (P < .01 and P < .05, respectively; Figure 1B ,C). An increase in respiratory drive can be triggered by blood gas instability. To assess stability, we measured SaO 2 by oximetry over 1 hour in freely moving mice. SaO 2 was reduced by~4% in SD55 Kcna1 À/À mice when compared to age-matched Kcna1 +/+ mice (92.8 AE 0.7% vs 97 AE 0.5%, n = 4, P < .001) ( Figure 1D ). SaO 2 was reduced by a similar degree during both rest and activity. Plotting all the raw data revealed that many Kcna1 À/À measurements were hypoxic (ie, SaO 2 drops below 90%) ( Figure 1E ). The percentage of hypoxic measurements was determined for each subject. Kcna1 +/+ mice rarely experienced hypoxia (with only 0.6 AE 0.3% of measurements having SaO 2 <90%), whereas 26 AE 0.7% of the measurements from Kcna1 À/À mice were considered hypoxic (n = 4, Figure 1F ). These data suggest that Kcna1 À/À mice experience frequent hypoxia.
3.2 | Apnea and hypopnea are severe in
Hypoxia can be caused by apnea or hypopnea (referred to as A-H). A-H frequently occurs during/after generalized tonic-clonic seizures and during the final events leading up to SUDEP in humans and in the Kcna1 À/À model. 6, 15 We hypothesized that Kcna1 À/À mice are more prone to A-H events at ages with increased probability of SD. Raw traces of eupnea, apnea, and hypopnea are depicted in Figure 2A -C, respectively. In the SD30 group, there were no differences in the number of apnea events among genotypes. A trend emerged in the SD55 group (P = .09;
significantly more apnea events when compared to agematched Kcna1 +/+ and Kcna1 +/À littermates ( Figure 2D ).
Of interest, hypopnea was highest in the SD30 Kcna1 À/À cohort and significantly diminished with age ( Figure 2E) . A-H rarely occurred in Kcna1 +/+ and Kcna1 +/À mice.
Kcna1
À/À mice spent 8-18% of time monitored in A-H, compared with only 1-4% for Kcna1 +/+ and Kcna1 +/À mice ( Figure 2F ). It is important to note that these measurements occurred in the absence of seizures. These data suggest that a critical period exists and the potential conversion of hypopnea events to apnea may indicate a dysfunction in circuitry and systems responsible for preventing apnea onset. 33 AE 3% higher than baseline sRaw). Irrespective of whether bronchoconstriction occurred, we classified 3 distinct respiratory patterns surrounding all A-H events (types 1-3). The incidence of each type was similar across ages (data not shown) and differed among genotypes. As depicted in Figure 3A , type 1 A-H events were preceded by tachypnea (rapid breathing and increased V T ), and were then followed by eupnea (normal breathing). Type 2 A-H events were preceded and followed by eupnea ( Figure 3B ) and type 3 events were preceded by eupnea and then followed by tachypnea ( Figure 3C ). A majority of Kcna1 +/+ and Kcna1 +/À A-H events were type 1 (29/33 Kcna1 +/+ and 32/35 Kcna1 +/À events; Figure 3D ).
In contrast, Knca1 À/À mice had 2 differences in their A-H phenotypes. Knca1 À/À mice had significantly fewer type 1
A-H events (42%) and a greater number of type 2 and 3 A-H events (35% and 23% of events, respectively; Figure 3D ). It is interesting to note that in Kcna1 À/À mice it was common to observe an A-H event that was either preceded or followed by tachypnea, to then be followed by another A-H event, in a repeating pattern ( Figure 3E ). Collectively, these data suggest that Kcna1 À/À mice are more prone to A-H events and that the typical respiratory responses surrounding apnea events may be dysregulated or these responses are compensatory in Kcna1 À/À mice. indicated by reduced breathing rates, tidal volume, minute ventilation, peak inspiratory and expiratory flow, and respiratory drive, whereas inspiration time, expiration time, and specific airway resistance were increased. Because there were no differences across ages, data were combined across age for both Kcna1 +/+ and Kcna1 +/À mice for each end point (depicted in gray in Figure 4 ). In contrast, MCh provoked hyperventilation in Kcna1 À/À mice, indicated by increased breathing rate, minute ventilation, peak inspiratory and expiratory flow, and respiratory drive, along with a decrease in inspiration time and expiration time ( Figure 4A-I) . Of interest, the overall response was attenuated as Kcna1 À/À mice aged. MCh provoked seizures in only Kcna1 À/À mice in a concentration-dependent manner.
All Kcna1 À/À mice experienced seizures by 200 mg/mL MCh ( Figure 5A ).
| Kcna1
À/À mice become more sensitive to MCh-induced tachypnea and seizures with age
Kcna1
À/À mice developed greater sensitivity to MCh as they aged. The EC 50 for seizure induction in the SD30 group was 40.8 mg/mL. This significantly decreased to 11.9 mg/mL, representing a 71% overall reduction with age (P < .0001; Figure 5A ). In the SD30 cohort, the EC 50 s for inspiration time, expiration time, and breathing rate werẽ 40-45 mg/mL and decreased 35-50% as mice approached SD (P < .0001, P < .0001, P < .0001; Figure 5B -D). MCh-induced seizures resulted in the death of one SD30 and 2 SD55 Kcna1 À/À mice. These 3 mice died at P36, P45, and P46 after experiencing severe seizures. This presented the opportunity to determine whether these susceptible mice had distinguishing respiratory characteristics, the hypothesis being that they would resemble the SD90 cohort. One baseline parameter that distinguished SD90 Figure 6C ). Kcna1 and E, respiratory drive (V T /T i : F (2,203) = 31.9, P < .0001); and decreased F, tidal volume (V T : F (2,203) = 22.5, P < .0001), G, inspiratory time (T i : F (2,203) = 54.8, P < .0001), and H, expiratory time (T e : F (2,203) = 41.3, P < .0001), with (I) little effect on specific airway resistance (sRaw: F (2,203) = 5.7, P < .005). Significance was determined by 2-way ANOVA with repeated measures followed by Tukey's multiple comparisons test; n = 5-7, gray * P < .05, ** P < .01, *** P < .001 indicates P32-36 and P48-56 Kcna1 À/À cohorts differ from
This is the first study demonstrating that changes in respiratory function are progressive with age in Kcna1 À/À mice, which may promote respiratory failure prior to SD. (1) Kcna1 À/À mice experience chronic blood gas instability as evidenced by frequent seizures, chronic oxygen desaturation, frequent A-H, the unusual breathing sequence of repeating patterns of tachypnea-A-H, increased tidal volume, and the paradoxical MCh-induced hyperventilation. Blood gas instability triggers a compensatory increase in respiratory drive. Thus the increase in basal respiratory drive as Kcna1 À/À mice aged may indeed be compensatory.
(2) The MCh challenge unveiled further respiratory Hyperexcitable phrenic nerves of Kcna1 À/À mice may contribute to increased respiration rate, an endpoint that was similar across age. We focused on endpoints that changed with age, as these may implicate additional factors and have relevance to SUDEP susceptibility. Our data are consistent with the notion that Kcna1 À/À mice exhibit chemoresponsive instability. Kcna1 À/À mice experience chronic oxygen desaturation, frequent seizures, and A-H, which have been shown to be associated with elevated CO 2 (hypercapnia) and hypoxia. 4, 8, [22] [23] [24] In the seminal report by Ryvlin et al., the terminal GTC seizure was followed by a brief period of tachypnea, and then bouts of apnea, and finally complete respiratory arrest. 9 A similar breathing sequence of increased breathing rate followed by apnea was detected in Kcna1 À/À mice. Tachypnea is increased respiration rate (reflected by elevated breathing rate and shortened inspiration and expiration time). Hyperventilation is an increase in respiration rate and depth (reflected by increased tidal volume and peak inspiratory and expiratory flow). Tachypnea or hyperventilation is typically followed by arousal, not apnea. Hyperventilation-induced apnea is rare and is the result of chemoresponsive instability. Hyperventilation-induced apnea has been reported to occur in people with central apnea or respiratory failure. [25] [26] [27] [28] This suggests that chemoresponsive instability may occur in patients prior to SUDEP and if it occurs early, hyperventilation-induced apnea may provide a novel marker of SUDEP risk. Respiratory drive is an endogenous tool that is increased to promote blood gas stability. For example, a buildup of CO 2 in the lungs will elevate blood CO 2 levels to signal peripheral and central chemoreceptors to increase respiration rate, which in turn stabilizes blood gasses. Indeed, as Kcna1 À/À mice approach SD, basal respiratory drive and peak inspiratory flow are uniquely increased. Respiratory drive reflects the volume of air that enters and exits the lungs in one cycle normalized to inspiration time. Increased peak inspiratory flow indicates deeper inspiration. Respiratory drive and inspiration can be influenced by central input to the medulla where preinspiratory, inspiratory, and expiratory neurons control the timing and air flow of inspiration and expiration. Orexin neurons in the lateral hypothalamus project to medullary preinspiratory and inspiratory neurons and are upstream of intercostal muscle-, phrenic nerve-, and diaphragm-ventilator responses, influencing volume, inspiration, and overall respiratory drive. [30] [31] [32] [33] Chemoresponsive orexin neurons increase firing in response to hypercapnia and hypoxia to increase breathing rate. [34] [35] [36] [37] We have previously found that orexin protein levels are elevated in the lateral hypothalamus of Kcna1 À/À mice. 38 Therefore, increased orexin neuronal activation may be a central driver of increased respiratory responses of Kcna1 À/À mice. Indeed, orexin crosses the blood-brain barrier and is elevated in the plasma of patients with epilepsy and in patients with hypercapnic respiratory failure. 39, 40 Elevation of orexin may be a compensatory mechanism to increase respiratory drive in people with respiratory failure. Elevated orexin levels in people with epilepsy and in Kcna1 À/À mice may also be reflective of an endogenous compensatory mechanism to increase respiratory drive. 38 Ongoing studies are exploring the potential role of orexin in the respiratory dysfunction of Kcna1 À/À mice. 
| CONCLUSION
One SUDEP case study with long-term monitoring reported a change in heart rate variability preceding the final seizure and SD when compared to within-subject data 7 months earlier. 7 Although it was not clear how early the change occurred, it suggests a temporal window to detect withinsubject changes that may occur in people at high risk for SUDEP. Data reported herein indicate that a temporal window of opportunity may exist to identify chemoresponsive instabilities to possibly identify/develop/implement treatments to postpone or prevent SUDEP; however, additional preclinical and clinical studies are required.
